AYALA PHARMACEUTICALS INC's ticker is AYLA and the CUSIP is 05465V108. A total of 14 filers reported holding AYALA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $862 | -100.0% | 2,153,273 | 0.0% | 0.02% | -64.2% |
| Q3 2022 | $2,153,000 | -8.3% | 2,153,273 | 0.0% | 0.05% | +8.2% |
| Q2 2022 | $2,347,000 | -72.6% | 2,153,273 | -0.0% | 0.05% | -65.0% |
| Q1 2022 | $8,572,000 | -53.2% | 2,153,860 | +0.0% | 0.14% | -59.5% |
| Q4 2021 | $18,328,000 | +305366.7% | 2,153,648 | +406248.7% | 0.35% | – |
| Q3 2021 | $6,000 | +20.0% | 530 | +15.7% | 0.00% | – |
| Q2 2021 | $5,000 | – | 458 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harel Insurance Investments & Financial Services Ltd. | 2,153,273 | $862 | 0.02% |
| Psagot Value Holdings Ltd. / (Israel) | 36,232 | $14 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 56,900 | $23,944 | 0.00% |
| Ameliora Wealth Management Ltd. | 750 | $316 | 0.00% |
| Renaissance Technologies | 53,600 | $21 | 0.00% |
| Avantax Planning Partners, Inc. | 10,000 | $4,001 | 0.00% |
| UBS Group AG | 1,010 | $404 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 10,596 | $4 | 0.00% |
| MORGAN STANLEY | 13,931 | $5,574 | 0.00% |